Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DAVID who wrote (20794)	4/19/1999 12:24:00 PM
From: VLAD	Respond to of 23519

DAVID, Good Question! I don't believe that the FDA could be sued in this type of situation. As far as Pfizer goes.....about 6 months ago I spoke with Pfizer IR. I asked them if I could obtain information regarding the number of individual lawsuits filed against Pfizer for Viagra related adverse reaction. I was told that someone would get back to me and as would be expected they never provided me with this information. You may remember the reports on CNBC regarding American Home Products and the Fen-Phen mess. It was reported that AHP was attempting to take any valid suit and settle out of court. This way they keep a low profile on the entire issue. I don't remember the amount the reported said AHP expected to pay out in settlements but it was very large. Usually a lawyer who is on top of this type of legal matter would rather not have a class action. This is because he can make more money by getting large settlements on a handful of clients rather than having a class action where the settlement pie ends up getting split into many slivers. If enough suits are filed, the court system may decide to turn the case into a class act so as not to tie up the courts with the same legal issue (ie Pfizer knowingly marketing/promoting an unsafe drug with improper labeling). I'm looking forward to the annual report on Viagra.